654 related articles for article (PubMed ID: 33713370)
1. A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis.
Gouverneur A; Ferreira A; Morival C; Pageot C; Tournier M; Pariente A
Br J Clin Pharmacol; 2021 Oct; 87(10):3971-3977. PubMed ID: 33713370
[TBL] [Abstract][Full Text] [Related]
2. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
[TBL] [Abstract][Full Text] [Related]
3. Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis.
Merino D; Gérard AO; Van Obberghen EK; Ben Othman N; Ettore E; Giordana B; Viard D; Rocher F; Destere A; Benoit M; Drici MD
J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807172
[TBL] [Abstract][Full Text] [Related]
4. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
5. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
6. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
7. Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies.
Cepaityte D; Siafis S; Papazisis G
Behav Brain Res; 2021 Apr; 404():113168. PubMed ID: 33581145
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.
Burk BG; DiGiacomo T; Polancich S; Pruett BS; Sivaraman S; Birur B
Acta Psychiatr Scand; 2023 Jul; 148(1):32-46. PubMed ID: 37194481
[TBL] [Abstract][Full Text] [Related]
9. Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).
Montastruc F; Salvo F; Arnaud M; Bégaud B; Pariente A
Drug Saf; 2016 Jul; 39(7):689-96. PubMed ID: 26961536
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine-Related Somnambulism: A Systematic Review of Literature and a Case Report of Anorexia Nervosa.
de Filippis R; Guinart D; Rania M; Carbone EA; Gaetano R; Segura-Garcia C
J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):658-666. PubMed ID: 34668875
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F
Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Lertxundi U; Erezuma I; Hernandez R; Medrano J; Garcia M; Aguirre C
Int Clin Psychopharmacol; 2019 Mar; 34(2):89-92. PubMed ID: 30531551
[TBL] [Abstract][Full Text] [Related]
15. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
Cohrs S
CNS Drugs; 2008; 22(11):939-62. PubMed ID: 18840034
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
Bordet C; Garcia P; Salvo F; Touafchia A; Galinier M; Sommet A; Montastruc F
Psychopharmacology (Berl); 2023 Jan; 240(1):199-202. PubMed ID: 36515735
[TBL] [Abstract][Full Text] [Related]
18. Risk excess of mortality and use of antipsychotics: a case-noncase study.
Martín Arias LH; Treceño Lobato C; Pérez García S; Sáinz Gil M; Sanz Fadrique R; García Ortega P
Int Clin Psychopharmacol; 2017 Jan; 32(1):1-5. PubMed ID: 27602888
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
